A comparative study of the use of bioactive glass S53P4 and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis: A retrospective comparative study

Bone and Joint Journal

Volumn 96 B, Issue 6, 2014, Pages 845-850

  Romano C L ^a   Logoluso, N ^a   Meani, E ^a,b   Romano D ^a   De Vecchi, E ^a   Vassena, C ^a   Drago, L ^a  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b G Pini Orthopaedic Institute   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; CALCIUM SULFATE; GLASS; HYDROXYAPATITE;

ADULT; ARTICLE; BONE MATRIX; BONE PROSTHESIS; CHRONIC OSTEOMYELITIS; CLINICAL ARTICLE; DEBRIDEMENT; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; FRACTURE; HUMAN; INFECTION CONTROL; KIDNEY FAILURE; MALE; PATHOGEN CLEARANCE; PNEUMONIA; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY;

BIOGLASS; BONE; BONE SUBSTITUTE; INFECTION; OSTEOMYELITIS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; BONE SUBSTITUTES; CALCIUM SULFATE; CHRONIC DISEASE; COHORT STUDIES; COMBINED MODALITY THERAPY; DEBRIDEMENT; FEMALE; FOLLOW-UP STUDIES; GLASS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEOMYELITIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; WOUND HEALING; YOUNG ADULT;

EID: 84902595065     PISSN: 20494394     EISSN: 20494408     Source Type: Journal    
DOI: 10.1302/0301-620X.96B6.33014     Document Type: Article

References (38)

1. Romanò CL, Romanò D, Logoluso N, Drago L. Bone and joint infections in adults: a comprehensive classification proposal. Eur Orthop Traumatol 2011;1:207-217.
2. Cierny G 3rd, Mader JT, Penninck JJ. A clinical staging system for adult osteomyelitis. Clin Orthop Relat Res 2003;414:7-24.
3. McPherson EJ, Woodson C, Holtom P, et al. Periprosthetic total hip infection: outcomes using a staging system. Clin Orthop Relat Res 2002;403:8-15.
4. Haas DW, McAndrew MP. Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment. Am J Med 1996;101:550-561.
5. Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004 Jul;364:369-379.
6. Bridgens J, Davies S, Tilley L, Norman P, Stockley I. Orthopaedic bone cement: do we know what we are using? J Bone Joint Surg [Br] 2008;90-B:643-647.
7. Anagnostakos K, Kelm J. Enhancement of antibiotic elution from acrylic bone cement. J Biomed Mater Res B Appl Biomater 2009;90:467-475.
8. Webb JC, Spencer RF. The role of polymethylmethacrylate bone cement in modern orthopaedic surgery. J Bone Joint Surg [Br] 2007;89-B:851-857.
9. Parsons B, Strauss E. Surgical management of chronic osteomyelitis. Am J Surg 2004;188(1A Suppl):57-66.
10. Anagnostakos K, Hitzler P, Pape D, Kohn D, Kelm J. Persistence of bacterial growth on antibiotic-loaded beads: is it actually a problem? Acta Orthop 2008;79:302-307.
11. Hanssen AD. Local antibiotic delivery vehicles in the treatment of musculoskeletal infection. Clin Orthop Relat Res 2005;437:91-96.
12. McLaren AC. Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin Orthop Relat Res 2004;427:101-106.
13. Zalavras CG, Patzakis MJ, Holtom P. Local antibiotic therapy in the treatment of open fractures and osteomyelitis. Clin Orthop Relat Res 2004;427:86-93.
14. Hu S, Chang J, Liu M, Ning C. Study on antibacterial effect of 45S5 Bioglass. J Mater Sci Mater Med 2009;20:281-286.
15. Leppäranta O, Vaahtio M, Peltola T, et al. Antibacterial effect of bioactive glasses on clinically important anaerobic bacteria in vitro. J Mater Sci Mater Med 2008;19:547-551.
16. Day RM. Bioactive glass stimulates the secretion of angiogenic growth factors and angiogenesis in vitro. Tissue Eng 2005;11:768-777.
17. Arkudas A, Balzer A, Buehrer G, et al. Evaluation of angiogenesis of bioactive glass in the arteriovenous loop model. Tissue Eng Part C Methods 2013;19:479-486.
18. Lindfors NC, Hyvönen P, Nyyssönen M, et al. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. Bone 2010;47:212-218.
19. Välimäki VV, Aro HT. Molecular basis for action of bioactive glasses as bone graft substitute. Scand J Surg 2006;95:95-102.
20. Stoor P, Söderling E, Salonen JI. Antibacterial effects of a bioactive glass paste on oral microorganisms. Acta Odontol Scand 1998;56:161-165.
21. Munukka E, Leppäranta O, Korkeamäki M, et al. Bactericidal effects of bioactive glasses on clinically important aerobic bacteria. J Mater Sci Mater Med 2008;19:27-32.
22. Coraça-Huber DC, Fille M, Hausdorfer J, Putzer D, Nogler M. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro. J Orthop Res 2014;32:175-177.
23. Silvola JT. Mastoidectomy cavity obliteration with bioactive glass: a pilot study. Otolaryngol Head Neck Surg 2012;147:119-126.
24. Peltola M, Aitasalo K, Suonpää J, Varpula M, Yli-Urpo A. Bioactive glass S53P4 in frontal sinus obliteration: a long-term clinical experience. Head Neck 2006;28:834-841.
25. Sarin J, Grénman R, Aitasalo K, Pulkkinen J. Bioactive glass S53P4 in mastoid obliteration surgery for chronic otitis media and cerebrospinal fluid leakage. Ann Otol Rhinol Laryngol 2012;121:563-569.
26. McAndrew J, Efrimescu C, Sheehan E, Niall D. Through the looking glass; bioactive glass S53P4 (BonAlive®) in the treatment of chronic osteomyelitis. Ir J Med Sci 2013;182:509-511.
27. Drago L, Signori V, De Vecchi E, et al. Use of dithiothreitol to improve the diagnosis of prosthetic joint infections. J Orthop Res 2013;31:1694-1699.
28. No authors listed. BLAST http://blast.ncbi.nlm.nih.gov/Blast.cgi (date last accessed 21 March 2014).
29. Geurts J, Chris Arts JJ, Walenkamp GH. Bone graft substitutes in active or suspected infection. Contra-indicated or not? Injury 2011;42(Suppl 2):S82-S86.
30. Stoor P, Pulkkinen J, Grénman R. Bioactive glass S53P4 in the filling of cavities in the mastoid cell area in surgery for chronic otitis media. Ann Otol Rhinol Laryngol 2010;119:377-382.
31. Cui X, Gu Y, Li L, et al. In vitro bioactivity, cytocompatibility, and antibiotic release profile of gentamicin sulfate-loaded borate bioactive glass/chitosan composites. J Mater Sci Mater Med 2013;24:2391-2403.
32. Xie Z, Cui X, Zhao C, et al. Gentamicin-loaded borate bioactive glass eradicates osteomyelitis due to Escherichia coli in a rabbit model. Antimicrob Agents Chemother 2013;57:3293-3298.
33. Wilson AP, Treasure T, Sturridge MF, Grüneberg RN. A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis. Lancet 1986;1:311-313.
34. Wilson AP, Gibbons C, Reeves BC, et al. Surgical wound infection as a performance indicator: agreement of common definitions of wound infection in 4773 patients. BMJ 2004;329:720.
35. Hench LL, Paschall HA. Direct chemical bond of bioactive glass-ceramic materials to bone and muscle. J Biomed Mater Res 1973;7:25-42.
36. Jones JR. Review of bioactive glass: from Hench to hybrids. Acta Biomater 2013;9:4457-4486.
37. Cormack AN, Tilocca A. Structure and biological activity of glasses and ceramics. Philos Trans A Math Phys Eng Sci 2012;370:1271-1280.
38. Drakou A, Karaliotas GI, Sakellariou V, et al. The use of a calcium hydroxyapatite antibiotic carrier (PerOssal*) in long bone chronic osteomyelitis. J Bone Joint Surg [Br] 2011;93-BSuppl.III:323.